World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
54932
World Ranking
7518
National Ranking
733

Ian N. Bruce publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ian N. Bruce sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 638 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ian N. Bruce D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ian N. Bruce sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ian N. Bruce is affiliated with the University of Manchester in the United Kingdom. Their primary field of research is Medicine, with a focus on Rheumatology. Their scholarly output includes significant contributions in Immunology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, and Genetics.

The main topics of Ian N. Bruce's work encompass:

  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Atherosclerosis and Cardiovascular Diseases
  • Lymphoma Diagnosis and Treatment
  • Systemic Sclerosis and Related Diseases
  • Rheumatoid Arthritis Research and Therapies
  • T-cell and B-cell Immunology

The scientist has published extensively in a variety of journals, with frequent publications in these venues:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Lupus Science & Medicine
  • UNC Libraries
  • Arthritis & Rheumatology

Recent papers authored or co-authored by Ian N. Bruce include:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023, Annals of the Rheumatic Diseases
  • EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome, 2022, Annals of the Rheumatic Diseases
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force, 2021, Lupus Science & Medicine
  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II), 2023, The Lancet
  • A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus, 2022, Arthritis & Rheumatology

Frequent co-authors collaborating with Ian N. Bruce include:

  • David Isenberg
  • Caroline Gordon
  • Ann E. Clarke
  • Kenneth Kalunian
  • Ronald van Vollenhoven

Ian N. Bruce has also contributed to the academic literature in book form, with publications through Bloomsbury Academic eBooks, including a book titled Expressing Critical Thinking through Disciplinary Texts published in 2020.

Best Publications

  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

    Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

    Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon

  • Genome-wide association study identifies eight loci associated with blood pressure

    Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • Correction: Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis

    John Bowes;Ashley Budu-Aggrey;Ulrike Huffmeier;Steffen Uebe

  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus

    Eric F Morand;Richard Furie;Yoshiya Tanaka;Ian N Bruce

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci

    Ying Liu;Cynthia Helms;Wilson Liao;Lisa C. Zaba

  • BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

    D. A. Isenberg;A. Rahman;E. Allen;V. Farewell

  • Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

    Sergey Nejentsev;Joanna M. M. Howson;Neil M. Walker;Jeffrey Szeszko

  • The frequency and outcome of lupus nephritis: results from an international inception cohort study

    John G. Hanly;Aidan G. O'Keeffe;Li Su;Murray B. Urowitz

  • Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Ian N Bruce;Aidan G O'Keeffe;Vernon Farewell;John G Hanly

  • Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

    Daniel J Wallace;Richard A Furie;Yoshiya Tanaka;Kenneth C Kalunian

  • Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study

    Ian N. Bruce;Murray B. Urowitz;Dafna D. Gladman;Dominique Ibañez

  • Essential role for the p110δ phosphoinositide 3-kinase in the allergic response

    Khaled Ali;Antonio Bilancio;Matthew Thomas;Wayne Pearce

  • Rheumatoid arthritis association at 6q23.

    Wendy Thomson;Anne Barton;Xiayi Ke;Steve Eyre

  • Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.

    Pascal Furet;Vito Guagnano;Robin A. Fairhurst;Patricia Imbach-Weese

  • Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.

    Ulrike Hüffmeier;Steffen Uebe;Arif B Ekici;John Bowes

Frequent Co-Authors

Caroline Gordon
Caroline Gordon University of Birmingham
David A. Isenberg
David A. Isenberg University College London
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Murray B. Urowitz
Murray B. Urowitz University of Toronto
Susan Manzi
Susan Manzi Allegheny Health Network
Cynthia Aranow
Cynthia Aranow Feinstein Institute for Medical Research
Joan T. Merrill
Joan T. Merrill Oklahoma Medical Research Foundation
Munther A. Khamashta
Munther A. Khamashta King's College London
Graciela S. Alarcón
Graciela S. Alarcón University of Alabama at Birmingham
Kenneth C. Kalunian
Kenneth C. Kalunian University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but unsure about committing to medical school? There are numerous online degrees and career pathways that can help you enter or advance within the medical field. Nursing is a particularly popular choice, offering various flexible options for learners at different stages.

Many students start their journey by considering online adn programs, which provide a foundational entry point into nursing with a relatively fast track to becoming a registered nurse (RN). For current RNs, advancing their education through a bachelor’s degree is common, but cost can be a concern. It’s crucial to compare the average cost of rn to bsn programs before enrolling.

If you already hold a non-nursing bachelor’s degree, you might explore direct entry msn programs for non nurses online, which offer a pathway to an advanced nursing career without starting from scratch. For those looking to reach the highest levels of practice or academic research, pursuing an online nursing doctorate can open doors to leadership roles, teaching, and specialized practice areas.

Exploring these online nursing and healthcare pathways can help you find a flexible, affordable, and fulfilling route to a career in medicine-related fields in the USA.

Best Scientists Citing Ian N. Bruce

Trending Scientists

Recently Published Articles